http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2255024-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_129e393582e6bdf4029baf2206522f45 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5585 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5585 |
filingDate | 1998-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a343d91fa41f6487fb9f4adfc22b8e48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cdb344a62e20172339264d2c28f6f41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a4126b4ecc8d622f1650f72ef1de18a |
publicationDate | 1998-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2255024-A1 |
titleOfInvention | Protective agents for cells constituting nervous system |
abstract | Protective agents for cells constituting the nervous system which contain as the active ingredient prostaglandin I derivatives, preferably prostaglandin I2 derivatives and still preferably beraprost. Because of excellent protective effects on cells constituting the nervous system, these drugs are highly efficacious as preventives or remedies for peripheral nerve injury caused by cerebrovascular disorder, cranial nerve cell disorder, ischemic cerebral disorder, dementia, diabetic disorder, etc. |
priorityDate | 1997-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 131.